NewCo News: RxBio Works on Bridge from NIAID to BARDA
By Mari Serebrov
Wednesday, May 18, 2011
RxBio Inc. has been hard at work building the funding bridge it's counting on to take its lead candidate, RX100, down the home stretch toward approval.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.